Hypertension in HIV-infected patients: Prevalence and related factors

American Journal of Hypertension

Volumn 18, Issue 11, 2005, Pages 1396-1401

  Jericó, Carlos ^a   Knobel, Hernando ^a   Montero, Milagro ^a   Sorli, María L ^a   Guelar, Ana ^a   Gimeno, Juan L ^a   Saballs, Pere ^a   López Colomés, Jose L ^a   Pedro Botet, Juan ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Department of Medicine ^*  (Spain)

Author keywords

Antiretroviral therapy; HIV; Hypertension; Protease inhibitors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; AGE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIPID STORAGE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE;

ADULT; ANTI-HIV AGENTS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; SMOKING; SPAIN;

EID: 27644501987     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.016     Document Type: Article

References (27)

1. A. Carr Improving the study, analysis, and reporting of adverse events associated with antiretroviral therapy Lancet 360 2002 81 85
2. C. Hadigan, J.B. Meigs, C. Corcoran, P. Rietschel, S. Piecuch, N. Basgoz, B. Davis, P. Sax, T. Stanley, P.W. Wilson, R.B. D'Agostino, S. Grinspoon Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy Clin Infect Dis 32 2001 130 139
3. A. Carr HIV lipodystrophy risk factors, pathogenesis, diagnosis and management AIDS 17 Suppl 1 2003 141 148
4. A. Carr, K. Samaras, S. Burton, M. Law, J. Freund, D.J. Chisholm, D.A. Cooper A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 51 58
5. M. Mary-Krause, L. Cotte, A. Simon, M. Partisani, D. Costagliola Clinical Epidemiology Group from the French Hospital Database Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men AIDS 17 2003 2479 2486
6. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group Combination antiretroviral therapy and risk of myocardial infarction N Engl J Med 349 2003 1993 2003
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2496
8. S. Aoun, E. Ramos Hypertension in the HIV-infected patient Curr Hypertens Rep 2 2000 478 481
9. A.M. Cattelan, M. Trevenzoli, L. Sasset, L. Rinaldi, V. Balasso, P. Cadrobbi Indinavir and systemic hypertension AIDS 15 2001 805 807
10. F.R. Sattler, D. Qian, S. Louie, D. Johnson, W. Briggs, V. DeQuattro, M.P. Dube Elevated blood pressure in subjects with lipodystrophy AIDS 15 2001 2001 2010
11. M.J. Galindo Puerto AHT and HIV - a new problem? Nutr Metab Disord HIV Infect 1 2002 33 37
12. C. Gazzaruso, R. Bruno, A. Garzaniti, S. Giordanetti, P. Fratino, P. Sacchi, G. Filice Hypertension among HIV patients prevalence and relationships to insulin resistance and metabolic syndrome J Hypertens 21 2003 1377 1382
13. D.C. Chow, S.A. Souza, R. Chen, S.M. Richmond-Crum, A. Grandinetti, C. Shikuma Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy HIV Clin Trials 4 2003 411 416
14. Palacios R, Santos J, Castells E, Ruiz J, González M, Márquez M: Blood pressure increases in a cohort of naïve HIV-patients starting HAART. XV International AIDS Conference 2004, Bangkok.
15. B.M. Bergersen, L. Sandvik, O. Dunlop, K. Birkeland, J.N. Bruun Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls results from a Norwegian study of 721 patients Eur J Clin Microbiol Infect Dis 22 2003 731 736
16. Centers for Disease Control and Prevention 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 41 1992 1 19
17. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
18. M.P. Dube, J.H. Stein, J.A. Aberg, C.J. Fichtenbaum, J.G. Gerber, K.T. Tashima, W.K. Henry, J.S. Currier, D. Sprecher, M.J. Glesby Adult AIDS Clinical Trials Group Cardiovascular Subcommittee; HIV Medical Association of the Infectious Disease Society of America Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group Clin Infect Dis 37 2003 613 627
19. Joint National Committee The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 157 1997 2413 2446
20. K. Wolf-Maier, R.S. Cooper, J.R. Banegas, S. Giampaoli, H.W. Hense, M. Joffres, M. Kastarinen, N. Poulter, P. Primatesta, F. Rodriguez-Artalejo, B. Stegmayr, M. Thamm, J. Tuomilehto, D. Vanuzzo, F. Vescio Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States JAMA 289 2003 2363 2369
21. N. Friis-Moller, R. Weber, P. Reiss, R. Thiebaut, O. Kirk, A. d'Arminio Monforte, C. Pradier, L. Morfeldt, S. Mateu, M. Law, W. El-Sadr, S. De Wit, C.A. Sabin, A.N. Phillips, J.D. Lundgren DAD study group Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study AIDS 17 2003 1179 1193
22. C. Hadigan, J.B. Meigs, P.W.F. Wilson, R.B. D'Agostino, B. Davis, N. Basgoz, P.E. Sax, S. Grinspoon Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution Clin Infect Dis 36 2003 909 916
23. M. Saves, G. Chene, P. Ducimetiere, C. Leport, G. Le Moal, P. Amouyel, D. Arveiler, J.B. Ruidavets, J. Reynes, A. Bingham, F. Raffi French WHO MONICA Project and the APROCO (ANRS EP11) Study Group Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population Clin Infect Dis 37 2003 292 298
24. E.D. Frohlich, C. Grim, D.R. Labarthe, M.H. Maxwell, D. Perloff, W.H. Weidman Recommendations for human blood pressure determinations by sphygmomanometers report of a special task force appointed by the Steering Committee, American Heart Association Circulation 77 1988 501A 514A
25. T.J. Hemingway, D.A. Guss, D. Abdelnur Arm position and blood pressure measurement Ann Intern Med 140 2004 74 75
26. S. Tsiodras, C. Mantzoros, S. Hammer, M. Samore Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy a 5-year cohort study Arch Intern Med 160 2000 2050 2056
27. Centro Nacional de Epidemiología ISC III Vigilancia epidemiológica del Sida en España. Situación a 30 de junio de 2004 Bol Epidemiol Semanal 12 2004 137 148